The economic burden of gout on an employed population.
Curr Med Res Opin
; 22(7): 1381-9, 2006 Jul.
Article
en En
| MEDLINE
| ID: mdl-16834837
ABSTRACT
OBJECTIVE:
To examine the economic burden of illness of gout in an employed population, quantifying the impact on employers annual health benefit costs for medical and prescription claims, sick leave, short- and long-term disability, and workers' compensation.METHODS:
Adjudicated claims data from 300000 employees from 2001 through 2004 were utilized. T-tests were used to compare demographic data and medical costs and services by Agency for Healthcare Research and Quality (AHRQ) diagnostic categories. Two-part models were used to determine average annual health benefit costs overall and medical costs by place of delivery. A risk stratification quintile analysis was also performed utilizing gout-specific medical and pharmaceutical costs.RESULTS:
There were 1171 employees with gout identified (total n = 249 038). All demographic variables between the two groups were statistically different (pCONCLUSION:
Gout inflicts a substantial burden of illness upon employers in terms of medical and prescription costs, as well as other work-related benefits.
Buscar en Google
Bases de datos:
MEDLINE
Asunto principal:
Empleo
/
Gota
Tipo de estudio:
Health_economic_evaluation
/
Prognostic_studies
Límite:
Female
/
Humans
/
Male
/
Middle aged
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Curr Med Res Opin
Año:
2006
Tipo del documento:
Article
País de afiliación:
Estados Unidos